由中枢神经系统药物引起的阳性性:简短的案例系列和叙事审查
Annalisa Morgan1, Vineet Punia1,2
1Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
The Neurohospitalist
|June 19, 2024
概括
中枢神经系统 (CNS) 药物,包括抗发作药物 (ASM),可以矛盾地增加性. 本综述审查了关于中枢神经系统药物诱导性发病的临床病例和文献,从微妙的EEG变化到新发作的发作.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床神经科学 临床神经科学
背景情况:
- 作用于中枢神经系统 (CNS) 的药物可以意外地增加患者的性.
- 即使使用抗发作药物 (ASM) 和精神药物,也观察到这种效应.
- 了解这种悖论对于患者安全和治疗优化至关重要.
研究的目的:
- 讨论临床案例,说明发性对中枢神经系统药物反应的频谱.
- 分析现有的关于中枢神经系统药物如何影响发性药物的文献.
- 为了突出影响的范围,从增加间接性发性排泄 (IED) 到新发作.
主要方法:
- 审查三个不同的临床病例,涉及中枢神经系统药物诱导的发性变化.
- 分析有关中枢神经系统药物和性病原性相关科学文献.
- 脑电图 (EEG) 发现与临床表现的相关性.
主要成果:
- 中枢神经系统药物可以以各种方式表现出发性作用,包括增加IED,而没有临床发作.
- 一些病例在EEG上显示出增加的发性以及非性运动障碍.
- 其他情况涉及新发作 (de novo发作) 的出现,这些发作归因于中枢神经系统的药物暴露.
结论:
- 中枢神经系统药物与发作性有复杂的关系,能够抑制和引起发作.
- 临床警对于识别和管理药物诱导的发性变化至关重要.
- 需要进一步的研究,以阐明中枢神经系统药物诱导的发性背后的机制.
相关概念视频
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
385
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385
01:14Antiepileptic Drugs: Glutamate Antagonists
319
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
319
01:17Antiepileptic Drugs: Calcium Channel Blockers
369
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
369
01:20Antiepileptic Drugs: Potassium Channel Activators
169
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
169
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
01:08Antiepileptic Drugs: Sodium Channel Blockers
508
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
508